ESMO - Good science, better medicine, best practice
All
Clinical Trials
Drugs & Biologics
Webcasts
Monographs & Reviews
Biomarkers
Clinical Practice Guidelines
Targetscapes
Annals of Oncology
Esmo.org
News
e-Learning
Meeting Abstracts
Scientific Meeting Reports
Handbooks
Posters
Educational Books
Meeting Slides
Essentials for Clinicians
Oncology News
Research
Clinical Trials
Drugs & Biologics
Biomarkers
Targetscapes
Guidelines
Clinical Practice Guidelines
Consensus Statements
Guides for Patients
Mobile Guidelines
Publications & CME
Annals of Oncology
World Oncology Literature Service
Monographs & Reviews
Handbooks
Educational Books
e-Learning
Global Curriculum
Glossary of Molecular Biology
Meeting Abstracts
Essentials for Clinicians
Meeting Resources
Webcasts
Scientific Meeting Reports
Posters
Meeting Abstracts
Educational Books
Meeting Slides
Practice Tools
Slide Resources
ESMO Spotlights
Meeting Slides
Educational Slides
>>
Home
>
Oncology News
>
Vorinostat in combination with bortezomib: Final results from VANTAGE trials
Vorinostat in combination with bortezomib: Final results from VANTAGE trials
Please login to access this content
GEN_ApiIncViewed.aspx?nodeId=68411
Search within Oncology News
Summary
Headline
Content
All
TIME SPAN:
Full archive
Today
This week
Last month
From
To
Related Content
Please login to access this content
Close
Please Login
Invalid username/password.
Username:
Password:
Remember me!
Forgot your Password?
Use of OncologyPRO is subject to the
Conditions of Use
Not a member yet?
Discover myESMO